These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3081817)

  • 1. Serotherapy for AIDS and pre-AIDS syndrome.
    Sewell HF; Walker F
    Nature; 1986 Mar 13-19; 320(6058):113-4. PubMed ID: 3081817
    [No Abstract]   [Full Text] [Related]  

  • 2. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes.
    Prince HE; Kermani-Arab V; Fahey JL
    J Immunol; 1984 Sep; 133(3):1313-7. PubMed ID: 6235286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aids: results with antibodies questionable].
    Paris KA
    Fortschr Med; 1992 Jun; 110(18):16. PubMed ID: 1644392
    [No Abstract]   [Full Text] [Related]  

  • 4. [AIDS. Passive immunoneutralization in AIDS is unsuccessful].
    Gürtler L
    Fortschr Med; 1988 Dec; 106(36):9. PubMed ID: 3235017
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical improvement and partial correction of the T cell defects of acquired immunodeficiency syndrome (AIDS) and lymphoadenopathy syndrome (LAS) by a calf thymus acid lysate.
    Valesini G; Barnaba V; Levrero M; Balsano F; Segatto O; Natali PG
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):531-2. PubMed ID: 3488221
    [No Abstract]   [Full Text] [Related]  

  • 6. IVIG in AIDS.
    Pediatr Infect Dis J; 1991 Mar; 10(3):suppl 5-6. PubMed ID: 2041661
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulins offer hope in AIDS survival.
    Nurs Stand; 1993 Dec 16-Jan 5; 7(13-14):15. PubMed ID: 8427788
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic treatment of human kidney allograft recipients with a monoclonal antibody (33B3.1) directed against interleukin 2 receptor.
    Peyronnet P; Le Mauff B; Hourmant M; Cantarovich D; Dubigeon P; Olive P; Mawas C; Delaage M; Hirn J; Jacques Y
    Transplant Proc; 1988 Apr; 20(2):300-2. PubMed ID: 3129836
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
    Gluckman JC; Klatzmann D; Cavaille-Coll M; Brisson E; Messiah A; Lachiver D; Rozenbaum W
    Clin Exp Immunol; 1985 Apr; 60(1):8-16. PubMed ID: 3924452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive hyperimmune therapy: a viable treatment option for the patient with acquired immune deficiency syndrome.
    Raven NC
    J Intraven Nurs; 1994; 17(4):214-6. PubMed ID: 7965365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
    Shapiro ME; Kirkman RL; Reed MH; Puskas JD; Mazoujian G; Letvin NL; Carpenter CB; Milford EL; Waldmann TA; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):594-8. PubMed ID: 3103282
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin 2 therapy in infectious diseases: rationale and prospects.
    Siegel JP; Rook AH; Djeu JY; Quinnan GV
    Infection; 1984; 12(4):298-302. PubMed ID: 6092280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid: studies in patients with AIDS and related disorders.
    Prince HE; John JK
    Diagn Immunol; 1986; 4(6):306-11. PubMed ID: 3102150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with anti-interleukin-2 receptor monoclonal antibody.
    Strom TB; Gaulton GN; Kelley VE; Diamanstein T; Kupiec-Weglinski J; Tilney NL; Kirkman RL
    Prog Clin Biol Res; 1986; 224():227-38. PubMed ID: 3099309
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS and AIDS-related complex: oral manifestations and treatment.
    Andriolo M; Wolf JW; Rosenberg JS
    J Am Dent Assoc; 1986 Oct; 113(4):586-9. PubMed ID: 3464644
    [No Abstract]   [Full Text] [Related]  

  • 16. Human trials of AIDS vaccines: novel means of passive and active immunotherapy.
    Dalgleish AG
    AIDS; 1988; 2 Suppl 1():S129-31. PubMed ID: 3147663
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of treatment with anti-IL-2-receptor monoclonal antibody and CsA on peripheral nerve allograft rejection.
    Grochowicz PM; Romaniuk A; Diamantstein T; Olszewski WL
    Transplant Proc; 1987 Oct; 19(5):4302-3. PubMed ID: 3118540
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibodies for the diagnosis and treatment of infection.
    Young LS
    Bibl Cardiol; 1988; (43):146-52. PubMed ID: 3147655
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical localization of cells reacting with monoclonal antibodies directed against the interleukin-2 receptor of murine, rat and human origin.
    Takacs L; Osawa H; Törö I; Diamantstein T
    Clin Exp Immunol; 1985 Jan; 59(1):37-44. PubMed ID: 3918819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
    Kupiec-Weglinski JW; Di Stefano R; Stunkel KG; Grutzmann R; Theisen P; Araneda D; Tilney NL; Diamantstein T
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):272-5. PubMed ID: 3126574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.